John Tan

John Tan

Reed Smith

Contact  |  View Bio  |  RSS

Latest Publications

Share:

China Issues New Regulations Prohibiting Commercial Bribery in the Health Care Industry

In late December, China’s National Health and Family Planning Commission ("NHFPC"), the successor organization to the Ministry of Health, issued two sets of anti-corruption regulations for the health care industry: the 2013...more

1/31/2014 - Anti-Bribery Anti-Corruption Bribery CFDA China Healthcare

China’s Life Sciences Regulatory Crackdown: September 10 Update

The regulatory enforcement environment in China remains tense, as both the Chinese government and media bring new actions and allegations against life sciences manufacturers in both the pharmaceutical and device sectors. We...more

9/11/2013 - Biotechnology China Compliance Enforcement Life Sciences Medicare Pharmaceutical

China Life Sciences Health Industry Client Briefing – February 2013 (March 11, 2013)

In This Issue: New Drug GSP Issued: Supervision on Drug Distribution to be Enhanced (China Securities Journal 2013-02-20) – February 20, 2013; China to Encourage Innovative Drug Development (Xinhua News Agency...more

3/12/2013 - China Generic Drugs Life Sciences Medical Devices Pharmaceutical SFDA

New People's Republic of China (PRC) Regulations for Centralized Procurement of Medical Consumables Contain Significant Penalties...

On December 17 2012, China’s Ministry of Health, in conjunction with five other government agencies, issued the Trial Regulations on Centralized Procurement of High-Value Consumable Medical Supplies. These regulations, which...more

2/22/2013 - Bribery China Medical Consumables Ministry of Health Penalties

China Life Sciences Health Industry Client Briefing – January 2013 (February 21, 2013)

In This Issue: Li Keqiang Comments from the 12th Plenary Meeting of the Medical Reform Leading Group (USCBC 2012-01-06) – January 6, 2013; MOH Announces Roadmap for Medical Reform (USCBC 2012-01-10) – January 10, 2013;...more

2/22/2013 - China Chinese Medicine Drug Manufacturers Health Insurance Hospitals Life Sciences Medical Equipment Ministry of Health Pharmaceutical

China Life Sciences Health Industry Client Briefing - December 2012 (January 18, 2013)

Pharmaceuticals, Medical Devices, Health Care & Life Sciences - News & Regulations: ..Industry Calls for Reform of Lagging Drug Review System (Global Times 2012-12-02) – December 3, 2012...more

1/24/2013 - China Drug Manufacturers Healthcare Life Sciences Medical Devices Pharmaceutical Prescription Drugs

China Life Sciences and Health Industry Client Briefing – November 2012 (December 13, 2012)

In This Issue: Priorities, Practical Tips and Lessons Learned from Reed Smith’s China Device Regulatory Briefing on December 4, 2012; Programs of Designated Drug Production to be Initiated: Five to 10 Pilot Varieties...more

12/17/2012 - China FDA Licenses Life Sciences Medical Devices Pharmaceutical Stem cells

2012 FCPA Guidance: Key Points and Analysis

On November 14, 2012, the U.S. Department of Justice and the Securities and Exchange Commission released their long-awaited Foreign Corrupt Practices Act guidance in the form of a 120-page document entitled “A Resource Guide...more

11/26/2012 - Compliance DOJ FCPA FCPA Resource Guide SEC

8 Results
|
View per page
Page: of 1